Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01023061
What this trial is testing

Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage II Prostate CancerStage III Prostate Cancer+1 more
University of Washington 24
Testing effectiveness (Phase 2)WithdrawnNCT00003534
What this trial is testing

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Who this might be right for
Stage IV Prostate Cancer
Burzynski Research Institute
Testing effectiveness (Phase 2)Study completedNCT00022412
What this trial is testing

Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 60
Testing effectiveness (Phase 2)Study completedNCT00118092
What this trial is testing

17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00049257
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Not applicableStudy completedNCT00693238
What this trial is testing

Proton Therapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Florida 228
Testing effectiveness (Phase 2)Looking for participantsNCT07650240
What this trial is testing

Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

Who this might be right for
Recurrent Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8Castration-Sensitive Prostate Cancer+9 more
Mayo Clinic 202
Testing effectiveness (Phase 2)Study completedNCT00433446
What this trial is testing

S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 62
Testing effectiveness (Phase 2)Study completedNCT00188513
What this trial is testing

Intensity Modulated Radiation Therapy - Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 267
Testing effectiveness (Phase 2)Study completedNCT00258284
What this trial is testing

Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT01054079
What this trial is testing

Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
Wake Forest University Health Sciences 20
Large-scale testing (Phase 3)UnknownNCT00110162
What this trial is testing

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Peter MacCallum Cancer Centre, Australia 2,000
Testing effectiveness (Phase 2)Ended earlyNCT04019327
What this trial is testing

The Drugs Talazoparib and Temozolomide in Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT00062309
What this trial is testing

Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 307
Testing effectiveness (Phase 2)Looking for participantsNCT07192614
What this trial is testing

Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 52
Testing effectiveness (Phase 2)Looking for participantsNCT06582628
What this trial is testing

Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)

Who this might be right for
Metastatic Prostate Cancer
Fundacion Oncosur 78
Early research (Phase 1)Study completedNCT00026377
What this trial is testing

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 3
Testing effectiveness (Phase 2)Study completedNCT00020995
What this trial is testing

Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01153113
What this trial is testing

Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines

Who this might be right for
Metastatic Prostate Cancer
University of Florida
Next Page